Although only four studies are included that investigated androgens in patients with COVID-19, the results of this review suggest that testosterone may be reduced in male patients with COVID-19 compared to controls, and this is negatively associated with CRP as a systematic marker of inflammation. This evidence concerns the gene CRP and COVID-19.